Sign in
4

Changes in Ownership

Tyra Biosciences, Inc. Filed Acc 0000899243-21-036427

Chief Financial Officer acquired 21,254 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

van den Boom Esther · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2021-09-17 Conversion : show line 1 in the form +21,254 21,254 I

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-09-17 Conversion : show line 2 in the form Series A Preferred Stock −8,183 0 D
Loading xslF345X03/doc4.xml…